About this trial
aim of this study is to evaluate the efficacy of pulmonary rehabilitation program as a non-pharmacological treatment method to: Improve functional capacity as assessed by six-minute walking distance (6MWD) test. Improve dyspnea level as assessed by Medical Research Council (MRC) dyspnea scale. Improve pulmonary function tests and arterial blood gas.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
The patients fulfilled the criteria for COPD: the presence of a post bronchodilator FEV1 < 80% predicated together with an FEV1/FVC <0.70confirm the presence of airflow limitation that is not fully reversible.
COPD patients ranging from mild to severe according to GOLD [stages I-IV].
Asthmatic patients receive medical treatment for at least 6 months; and clinically stable (i.e., no exacerbation or changes in medication for ≥30 days).
None of the individuals had been engaged in any exercise-training program before participating in the study.
Disqualifiers
Age <18 years.
Pregnancy
Current Smokers
Patients that are incapable of exercising; unable to understand any questionnaire
Trial design
Parallel
Treatments tested in this trial
Breathing exercises
BehavioralBreathing exercises as diaphragmatic breathing exercises and pursued lip breathing and incentive spirometry
Treatment groups
Trial outcomes
Primary outcomes
Impact of breathing exercises on Forced expiratory volume on first second (FEV1) in liter
Effect of Breathing exercises on lung function using spirometry
Impact of breathing exercises on Forced vital capacity (FVC) in liter
Effect of Breathing exercises on lung function using spirometry
Sponsors and contacts
Click on the lead sponsor to view all of their trials.